Fujian Cosunter Pharmaceutical Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 379.76 million compared to CNY 370.01 million a year ago. Revenue was CNY 385.77 million compared to CNY 370.44 million a year ago.

Net loss was CNY 127.4 million compared to CNY 34.89 million a year ago. Basic loss per share from continuing operations was CNY 0.8004 compared to CNY 0.2335 a year ago. Diluted loss per share from continuing operations was CNY 0.8004 compared to CNY 0.2335 a year ago.